people < peptide < peptides

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by peptide

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000212 (2018)	Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Marina A. Shuklina [Russie] ; Eugenia S. Mardanova [Russie] ; Roman Y. Kotlyarov [Russie] ; Marina V. Potapchuk [Russie] ; Sergei A. Petrov [Russie] ; Elena A. Blokhina [Russie] ; Nikolai V. Ravin [Russie]	Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
000253 (2017)	Noemie Courtin [France] ; Aurelien Fotso Fotso [France] ; Pierre Fautrad [France] ; Floriane Mas [France] ; Marie-Christine Alessi [France] ; Beatrice Riteau [France]	Antiviral activity of Formyl Peptide Receptor 2 antagonists against influenza viruses
000349 (2017)	Marco R. Straus [États-Unis] ; Gary R. Whittaker [États-Unis]	A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site
000512 (2015)	S. K. Rosendahl Huber [Pays-Bas] ; M. G. M. Camps [Pays-Bas] ; R. H. J. Jacobi [Pays-Bas] ; J. Mouthaan [Pays-Bas] ; H. Van Dijken [Pays-Bas] ; J. Van Beek [Pays-Bas] ; F. Ossendorp [Pays-Bas] ; J. De Jonge [Pays-Bas]	Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets
000577 (2015)	Liudmila M. Tsybalova [Russie] ; Liudmila A. Stepanova [Russie] ; Victor V. Kuprianov [Russie] ; Elena A. Blokhina [Russie] ; Marina V. Potapchuk [Russie] ; Alexander V. Korotkov [Russie] ; Andrey N. Gorshkov [Russie] ; Marina A. Kasyanenko [Russie] ; Nikolai V. Ravin [Russie] ; Oleg I. Kiselev [Russie]	Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
000D92 (2010)	Guangyu Zhao [République populaire de Chine] ; Shihui Sun [République populaire de Chine] ; Lanying Du [États-Unis] ; Wenjun Xiao [République populaire de Chine] ; Zhitao Ru [République populaire de Chine] ; Zhihua Kou [République populaire de Chine] ; Yan Guo [République populaire de Chine] ; Hong Yu [République populaire de Chine] ; Shibo Jiang [États-Unis] ; Yuchun Lone [France] ; Bo-Jian Zheng [République populaire de Chine] ; Yusen Zhou [République populaire de Chine]	An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.
001864 (2001)	R. Arnon ; R. Tarrab-Hazdai ; T. Ben-Yedidia	Peptide-based Synthetic Recombinant Vaccines with Anti-viral Efficacy
001903 (2000)	H. Masaki [Japon] ; M. Tamura ; I. Kurane	Induction of cytotoxic T lymphocytes of heterogeneous specificities by immunization with a single peptide derived from influenza A virus.
001972 (1999)	D E Byers [États-Unis] ; K F Lindahl	Peptide affinity and concentration affect the sensitivity of M3-restricted CTLs induced in vitro.
001A24 (1999)	Tamar Ben-Yedidia [Israël] ; Hadar Marcus [Israël] ; Yair Reisner [Israël] ; Ruth Arnon [Israël]	Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection
002283 (1987)	E. Hamsíková ; H. Závadová ; M. Zaoral ; J. Jezek ; K. Bláha ; V. Vonka	Immunogenicity of a synthetic peptide corresponding to a portion of the heavy chain of H3N2 influenza virus haemagglutinin.
002884 (1979)	W. G. Laver [Australie] ; W. Gerhard [États-Unis] ; R. G. Webster [États-Unis] ; M. E. Frankel [États-Unis] ; G. M. Air [Australie]	Antigenic drift in type A influenza virus: Peptide mapping and antigenic analysis of A/PR/8/34 (HON1) variants selected with monoclonal antibodies
002A39 (1977)	N J Dimmock ; A S Carver ; S I Kennedy ; M R Lee ; S. Luscombe	Internal proteins of influenza virus: 35S-methionine peptide maps as genetic markers.
002C32 (1973)	Alan P. Kendal ; Michael P. Kiley	Characterization of Influenza Virus Neuraminidases: Peptide Changes Associated with Antigenic Divergence Between Early and Late N2 Neuraminidases

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "peptide" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "peptide" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    peptide
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021